(Q42586085)

3 November 2017

Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab (English)

1 reference

3 November 2017

1 reference

1 reference

Michael C Saavedra

1

1 reference

3 November 2017

Sanjiv Sur

series ordinal

2

1 reference

3 November 2017

19 January 2011

1 reference

Clinical and Molecular Allergy

3 November 2017

1 reference

3 November 2017

9

1 reference

3 November 2017

1

1 reference

3 November 2017

2

1 reference

Creative Commons Attribution 2.0 Generic

3 November 2017

start time

19 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1476-7961-9-2

0 references

cites work

Treatment of chronic autoimmune urticaria with omalizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031269

Effect of omalizumab on patients with chronic urticaria

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031269

Omalizumab-induced reductions in mast cell Fce psilon RI expression and function

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031269

Chronic urticaria: pathogenesis and treatment

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031269

Regulation of mast-cell and basophil function and survival by IgE.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031269

Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031269

Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031269

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031269

16 August 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21247438

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association between chronic urticaria and thyroid autoimmunity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21247438

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1476-7961-9-2

1 reference

Dimensions Publication ID

3 November 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1476-7961-9-2

1 reference

3 November 2017

PubMed publication ID

21247438

1 reference